Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIBUCAINE: 90 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
90
Total FAERS Reports
0
Deaths Reported
6
Hospitalizations
90
As Primary/Secondary Suspect
1
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Akron Pharma Inc.
Manufacturer
Discontinued
Status

Drug Class: Allergens [CS] · Route: TOPICAL · Manufacturer: Akron Pharma Inc. · FDA Application: 006203 · HUMAN OTC DRUG · FDA Label: Available

First Report: 201707 · Latest Report: 20200103

What Are the Most Common DIBUCAINE Side Effects?

#1 Most Reported
Weight decreased
30 reports (33.3%)
#2 Most Reported
Malaise
30 reports (33.3%)
#3 Most Reported
Insomnia
30 reports (33.3%)

All DIBUCAINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Insomnia 30 33.3% 0 1
Malaise 30 33.3% 0 1
Weight decreased 30 33.3% 0 1
Angina pectoris 29 32.2% 0 0
Appetite disorder 29 32.2% 0 0
Asthma 29 32.2% 0 0
Chest discomfort 29 32.2% 0 0
Chest pain 29 32.2% 0 0
Cough 29 32.2% 0 0
Depressed mood 29 32.2% 0 0
Depressive symptom 29 32.2% 0 0
Dyspnoea 29 32.2% 0 0
Dyspnoea exertional 29 32.2% 0 0
Fall 29 32.2% 0 0
Flank pain 29 32.2% 0 0
Heart sounds 29 32.2% 0 0
Influenza 29 32.2% 0 0
Injury 29 32.2% 0 0
Lower respiratory tract infection 29 32.2% 0 0
Nasal congestion 29 32.2% 0 0

Who Reports DIBUCAINE Side Effects? Age & Gender Data

Gender: 87.0% female, 13.0% male. Average age: 64.0 years. Most reports from: US. View detailed demographics →

Is DIBUCAINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2017 1 0 1
2019 8 0 0
2020 1 0 0

View full timeline →

What Is DIBUCAINE Used For?

IndicationReports
Product used for unknown indication 36
Haemorrhoids 28
Contusion 7
Infection 7
Skin abrasion 6

Other Drugs in Same Class: Allergens [CS]

Official FDA Label for DIBUCAINE

Official prescribing information from the FDA-approved drug label.

FDA Approved Uses (Indications)

​Use temporarily relieves pain and itching due to hemorrhoids and other anorectal disorders

Dosage & Administration

Directions Adults and children 12 years of age or older. If possible, clean the affected area by platting or blotting with an appropriate cleansing wipe, gently dry by patting or blotting with a tissue or a soft cloth before applying. Apply externally to the affected area up to 3 to 4 times daily. Children under 12 years of age. ask a doctor

Warnings

​Warnings ​For external use only.

Allergy Alert

Certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated does not subside or if redness, irritaion, swelling, bleeding or other symptoms develop or increase, discontinue use and ask a doctor. Do not use in or near the eyes in children under 2 years of age When using this product do not use more than directed unless directed by a doctor. do not put this product into the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days If pregnant or breast-feeding ask a health care professional before use. Keep out of reach of children. If swallowed, get medical help or contact a poison control center (1-800-222-1222) right away.

Active Ingredient

Drug Facts Active ingredient Purpose Dibucaine 1% Hemorrhoidal ointment

Inactive Ingredients

Inactive Ingredients Lanolin, Light Mineral Oil, Purified water, White Petrotalum